FDA 已批准 Organon 的 Vtama（tapinarof）乳膏（1%）用于治疗成人和 2 岁以下儿童的特应性皮炎 (AD)。据该公司称，该批准提前于其《处方药用户付费法案》的目标行动日期 2025 年 3 月 12 日获得，标志着一个重要的里程碑，因为该治疗提供了无类固醇的选择，没有标签警告、禁忌症或对治疗持续时间或受影响体表面积的限制。

As the Catechism of the Catholic Church teaches, “Adoring God, praying to him, offering him the worship that belongs to him…are acts of the virtue of religion which falls under obedience to ...

Organon (OGN) announced results from an analysis of the Phase 3 ADORING 3 open-label, long-term extension study evaluating VTAMA cream, 1% once daily in adults and children 2 years of age and ...